|
Volumn 81, Issue 9, 2006, Pages 692-695
|
AL amyloidosis associated with B-cell lymphoproliferative disorders: Frequency and treatment outcomes
|
Author keywords
AL amyloidosis; Frequency; Lymphoma; Treatment outcomes
|
Indexed keywords
AMYLOID;
IMMUNOGLOBULIN LIGHT CHAIN;
MELPHALAN;
PARAPROTEIN;
ADULT;
AGED;
AMYLOIDOSIS;
ARTICLE;
B LYMPHOCYTE;
CANCER SURVIVAL;
CELL SURVIVAL;
CLINICAL ARTICLE;
DISEASE COURSE;
FEMALE;
FREQUENCY ANALYSIS;
HIGH RISK PATIENT;
HUMAN;
LYMPHOMA;
LYMPHOPROLIFERATIVE DISEASE;
MALE;
OUTCOMES RESEARCH;
PLASMA CELL DYSCRASIA;
PRIORITY JOURNAL;
STEM CELL TRANSPLANTATION;
SYSTEMIC DISEASE;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
AMYLOIDOSIS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
B-LYMPHOCYTES;
BONE MARROW CELLS;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
MALE;
MELPHALAN;
MIDDLE AGED;
PARAPROTEINEMIAS;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
RADIOTHERAPY;
TREATMENT OUTCOME;
|
EID: 33748092565
PISSN: 03618609
EISSN: 10968652
Source Type: Journal
DOI: 10.1002/ajh.20635 Document Type: Article |
Times cited : (52)
|
References (6)
|